WO1998045260A1 - Process for stereoselective preparation of azetidinones - Google Patents

Process for stereoselective preparation of azetidinones Download PDF

Info

Publication number
WO1998045260A1
WO1998045260A1 PCT/KR1997/000070 KR9700070W WO9845260A1 WO 1998045260 A1 WO1998045260 A1 WO 1998045260A1 KR 9700070 W KR9700070 W KR 9700070W WO 9845260 A1 WO9845260 A1 WO 9845260A1
Authority
WO
WIPO (PCT)
Prior art keywords
chloride
substituted
process according
compound
titanium
Prior art date
Application number
PCT/KR1997/000070
Other languages
French (fr)
Inventor
Mi-Jung Lee
Taek-Hyun Yoon
In-Hee Lee
Hee-An Kwon
Tae-Seop Hwang
Original Assignee
Choongwae Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choongwae Pharmaceutical Co., Ltd. filed Critical Choongwae Pharmaceutical Co., Ltd.
Priority to AU27130/97A priority Critical patent/AU2713097A/en
Publication of WO1998045260A1 publication Critical patent/WO1998045260A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Definitions

  • the present invention relates to a process for stereoselective preparation of (3 S,4S)-3-[( 1 R)-hydroxyethyl]-4-acyl- 1 -p-methoxyphenyl- 2-azetidinone (1) (here-in-after, abbreviated as "azetidinone”) which is a useful intermediate for preparing carbapenem and penem type antibiotics.
  • Ri represents a substituted or non-substituted aryl group, or a substituted or non-substituted lower alkyl group
  • R2 as a protective group for ? -lactam ring, represents a substituted or non- substituted aryl group, or a substituted or non-substituted benzyl group.
  • Table 1 Yield of azetidinone ring formation in the rior art
  • PMP represents p-methoxyphenyl group
  • LiHMDS represents Lithium hexamethyldisilazide
  • R3 represents phenyl or a substituted aryl group
  • a represents a compound wherein R3 is phenyl
  • b represents a compound wherein RJ is p- chlorophenyl
  • c represents a compound wherein R3 is p- methylphenyl.
  • the object of the present invention is to provide a process for stereoselective preparation of azetidinones ( 1 ).
  • an azetidinone is stereoselectively prepared as shown in Scheme 2 below.
  • L- threonine is converted to (2R,3R)- epoxybutyric acid (2) by the use of a known procedure [Tae-sub Hwang et al., Korean Patent Laid-Open No.
  • a secondary amine (3) obtained by reacting R2-NH2 with a compound of general formula (4), is reacted with the (2R,3R)- epoxybutyric acid (2) to obtain (2R,3R)- epoxyamide represented by formula (5); which is then reacted with amine compound, dehydrating agent and Lewis acid in the presence of benzene or dichloromethane as a solvent at a temperature between 0 ° C and the reflux temperature of the solvent to stereoselectively give trans-azetidinone.
  • Step 2 It is a process for preparing the secondary amine represented by general formula (3) by reacting the compound of general formula (4) and a compound represented by R2-NH2 with a dehalogenating agent in the presence or absence of an inert organic solvent.
  • the compounds represented by R2-NH2 include aniline, p- anisidine, 2,4-dimethoxy aniline, 3,4-dimethoxy aniline, 2,4- dimetoxybenzylamine, or the like. Among these, p-anisidine is preferably used.
  • the compounds of general formula (4) include chloroacetone, chloroacetophenone, 2,4'-dichloroacetophenone, 2,4'- dibromoacetophenone, 2-bromo-4'-methylacetophenone, or the like. Among these, preferable are chloroacetone and chloroacetophenone.
  • the inert solvents used in the step include any organic solvent which can dissolve every compounds involved in the reaction, without participating the reaction under the given reaction condition or lowering the reactivity, and minimize the side reaction.
  • Preferable solvents include hydrocarbons such as hexane and benzene; ethers such as diethyl ether and tetrahydrofuran (THF); halogenated hydrocarbons such as dichloromethane, carbon tetrachloride, 1 ,2-dichloroethane and chloroform; esters such as methyl acetate and ethyl acetate; lower alcohols such as methanol and ethanol; and other solvents such as acetonitrile, toluene, N,N-dimethylformamide (DMF), and so on.
  • benzene is preferably used.
  • the dehalogenating agents which can be used in this step include alkali metal bases such as n-butyl lithium, lithium amide, sodium amide, sodium hydride and potassium hydride; organic tertiary amines such as triethylamine, pyridine, DBN and DBU; ammonium hydroxide and alkali metal hydroxides such as sodium hydroxide, potassium hydroxide. It is preferable to use triethyl amine in an amount of 1 to 5 equivalents.
  • the reaction temperature is properly selected between room temperature and the reflux temperature.
  • an acid halide process, a mixed anhydride process and an active ester process can be generally mentioned.
  • the active ester process is preferable as it minimizes the side reactions and increases the reaction yield under a mild reaction condition.
  • the activating agents for the active ester process include ethyl chloroformate, isopropylchloroformate, and isobutyl chloroformate. Ethylchloroformate in an amount of 1 to 3 equivalents is preferably used.
  • tertiary amines such as triethylamine, pyridine, N,N-dimethylaminopyridine, N-methylmorpholine, and bicyclic amines (e.g. DBN, DBU) can be used. It is preferable to use 1 to 5 equivalents of triethylamine or N-methylmorpholine.
  • the reaction temperature is preferably selected between -40 ° C and room temperature.
  • (2R,3R)-epoxyamide compound of general formula (5) obtained from ⁇ Step 3> is reacted with an amine compound, a dehydrating agent and a Lewis acid.
  • the ketone group of (2R,3R)-epoxyamide compound (5) is substituted by an enamine, which then goes through intramolecular cyclization with Lewis acid to stereoselectively give trans-azetidinone.
  • a dialkyl amine such as dimethylamine, diethylamine, dipropylamine or diisobutylamine; or a heterocyclic secondary amine such as pyrrolidine, piperidine, hexamethylene imine, morpholine, N-methyl piperazine, N-phenyl piperazine, azetidine or aziridine
  • Pyrrolidine in an amount of 1 to 10 equivalents is preferably used.
  • the dehydrating agents include phosphorus pentoxide, molecular sieve, magnesium sulfate, sodium sulfate and calcium chloride.
  • calcium hydride, titanium(IV) chloride or tris-dialkylaminoborane can be used.
  • the Lewis acids which can be used in this step include zinc chloride, zinc bromide, tin(IV) chloride, boranetrifluoride ethyl ether compound, aluminum chloride, lithium chloride, thallium chloride or titanium(IV) chloride and chlorotrimethylsilane.
  • Titanium(IV) chloride is preferably used in an amount of 0.5 to 5 equivalents as a dehydrating agent and, at the same time, a Lewis acid.
  • the reaction temperature is preferably selected between 0 ° C and reflux temperature.
  • benzene, dichloromethane, acetonitrile or tetrahydrofuran may be used.
  • benzene or dichloromethane is preferably used.
  • zinc chloride or zinc bromide is used as a Lewis acid, the reaction may be performed in a milder condition as compared to the reaction using titanium(IV) chloride, but shows lower stereoselectivity.
  • the reaction is preferably carried out by using 1 - 10 equivalents of pyrrolidine as an amine compound and 0.5 to 5 equivalents of phosphorus pentoxide as a dehydrating agent at a temperature between room temperature and reflux temperature in the presence of reaction solvent such as benzene, chloroform and acetonitrile.
  • the present invention provides a process for stereoselective preparation of azetidinone ring starting from L-threonine which can be abundantly supplied from the nature, it is economically advantageous.
  • azetidinones can be prepared in a high yield and high stereoselectivity.
  • Example 1 (2R,3R)-Epoxybutyric acid After chilling 7.5N-HC1 (90 ml), L-threonine (17.86 g, 0.15 mol) was added thereto and dissolved therein. As maintaining the reaction temperature at room temperature, NaN ⁇ 2 (18.2 g) was added thereto in small portions over 5 hours. After cooling the interior temperature of the reactor to 0 ° C , 40% solution of NaOH was slowly added dropwise, and the mixture stirred at room temperature for 15 hours. As restraining the elevation of the reaction temperature, the reaction mixture was acidified (to pH 2.0) with 6N-HC1, and then extracted from ethyl acetate (twice with each 400 ml). The combined organic layer was dried over anhydrous sodium sulfate (10 g), and concentrated under reduced pressure to obtain relatively pure title compound (14.3 g, yield: 93%). The product can be directly used in the next step without further purification.
  • Example 2 was added, and the reaction temperature was raised to room temperature. Then the reaction mixture was stirred for 2 hours. After the completion of the reaction, the organic layer was washed with 2N-
  • Example 6 (3S,4S)-3-[(lR)-Hydroxyethyl]-4-acetyl-l-p- methoxyphenyl-2-azetidinone (Method A) (2R,3R)-N-(Acetyl)methyl-N-p-methoxyphenyl-2,3-epoxy butyric amide (5 g, 19 mmol) prepared in Example 4 was dissolved in benzene (50 ml). The interior temperature of the reactor is lowered to 0 ° C , and pyrrolidine (7.8 ml, 94.9 mmol) was added to the mixture.

Abstract

The present invention relates to a process for stereoselective preparation of (3S,4S)-3- [(1R)-hydroxyethyl]-4-acyl-1-p-methoxyphenyl-2-azetidinone which is a useful intermediate for preparing carbapenem and penem type antibiotics.

Description

TITLE OF THE INVENTION
Process for stereoselective preparation of azetidinones
Technical Field
The present invention relates to a process for stereoselective preparation of (3 S,4S)-3-[( 1 R)-hydroxyethyl]-4-acyl- 1 -p-methoxyphenyl- 2-azetidinone (1) (here-in-after, abbreviated as "azetidinone") which is a useful intermediate for preparing carbapenem and penem type antibiotics.
1
In the formula, Ri represents a substituted or non-substituted aryl group, or a substituted or non-substituted lower alkyl group; and R2, as a protective group for ? -lactam ring, represents a substituted or non- substituted aryl group, or a substituted or non-substituted benzyl group.
Background Art
A process for preparation of the compound of general formula (1) has been reported in the literature [Synlett. Kugelmam et al., 431, 1990], wherein the object compound, trans-azetidinones (7a-c) are obtained by azetidinone ring formation with a yield of 67 to 89%, depending upon the substituents of the compound (See Scheme 1 below). However, the process has a problem in that by-products such as bicyclic hemiketal compound (8a-c) and cis-azetidinone (9a) occurs in an amount of 9% to 26%, depending on the substituents of each compound, as shown in Table 1.
Scheme 1
Figure imgf000004_0001
7a, 7b, 7c 8a, 8b , 8c 9a
Table 1 : Yield of azetidinone ring formation in the rior art
Figure imgf000004_0002
In the above scheme and table, PMP represents p-methoxyphenyl group, LiHMDS represents Lithium hexamethyldisilazide, and R3 represents phenyl or a substituted aryl group; a represents a compound wherein R3 is phenyl, b represents a compound wherein RJ is p- chlorophenyl, and c represents a compound wherein R3 is p- methylphenyl.
Disclosure of the invention The present inventors have performed intensive studies to overcome the problem as mentioned above, and, as a result, developed a novel process for stereoselective preparation of trans-azetidinone by using intramolecular cyclization of an enamine.
The object of the present invention is to provide a process for stereoselective preparation of azetidinones ( 1 ).
According to the present invention, an azetidinone is stereoselectively prepared as shown in Scheme 2 below. First, L- threonine is converted to (2R,3R)- epoxybutyric acid (2) by the use of a known procedure [Tae-sub Hwang et al., Korean Patent Laid-Open No. 96-41161]; a secondary amine (3), obtained by reacting R2-NH2 with a compound of general formula (4), is reacted with the (2R,3R)- epoxybutyric acid (2) to obtain (2R,3R)- epoxyamide represented by formula (5); which is then reacted with amine compound, dehydrating agent and Lewis acid in the presence of benzene or dichloromethane as a solvent at a temperature between 0 °C and the reflux temperature of the solvent to stereoselectively give trans-azetidinone.
Scheme 2
Figure imgf000005_0001
step 4
Figure imgf000005_0002
1
In the formula, Ri and R2 are defined as above. Now, the process according to the present invention (Scheme 2) is described step by step, in more detail.
Step 1
The procedure of <Step 1> has been disclosed by the present inventors et al., in Korea Patent Laid-Open No. 96-41161.
Step 2 It is a process for preparing the secondary amine represented by general formula (3) by reacting the compound of general formula (4) and a compound represented by R2-NH2 with a dehalogenating agent in the presence or absence of an inert organic solvent.
The compounds represented by R2-NH2 include aniline, p- anisidine, 2,4-dimethoxy aniline, 3,4-dimethoxy aniline, 2,4- dimetoxybenzylamine, or the like. Among these, p-anisidine is preferably used.
The compounds of general formula (4) include chloroacetone, chloroacetophenone, 2,4'-dichloroacetophenone, 2,4'- dibromoacetophenone, 2-bromo-4'-methylacetophenone, or the like. Among these, preferable are chloroacetone and chloroacetophenone. The inert solvents used in the step include any organic solvent which can dissolve every compounds involved in the reaction, without participating the reaction under the given reaction condition or lowering the reactivity, and minimize the side reaction. Preferable solvents include hydrocarbons such as hexane and benzene; ethers such as diethyl ether and tetrahydrofuran (THF); halogenated hydrocarbons such as dichloromethane, carbon tetrachloride, 1 ,2-dichloroethane and chloroform; esters such as methyl acetate and ethyl acetate; lower alcohols such as methanol and ethanol; and other solvents such as acetonitrile, toluene, N,N-dimethylformamide (DMF), and so on. Among these, benzene is preferably used. The dehalogenating agents which can be used in this step include alkali metal bases such as n-butyl lithium, lithium amide, sodium amide, sodium hydride and potassium hydride; organic tertiary amines such as triethylamine, pyridine, DBN and DBU; ammonium hydroxide and alkali metal hydroxides such as sodium hydroxide, potassium hydroxide. It is preferable to use triethyl amine in an amount of 1 to 5 equivalents. The reaction temperature is properly selected between room temperature and the reflux temperature.
Step 3
It is a process for reacting (2R,3R)-epoxybutyric acid (2) from <Step 1> and the secondary amine (3) from <Step 2> by using an amide bond coupling agent to synthesize (2R,3R)-epoxyamide compound of general formula (5). As the amide coupling process in this step, an acid halide process, a mixed anhydride process and an active ester process can be generally mentioned. Among them, the active ester process is preferable as it minimizes the side reactions and increases the reaction yield under a mild reaction condition. The activating agents for the active ester process include ethyl chloroformate, isopropylchloroformate, and isobutyl chloroformate. Ethylchloroformate in an amount of 1 to 3 equivalents is preferably used.
While the inert organic solvents mentioned in <Step 2> may be used in this step, preferable are dichloromethane and chloroform. As a compound for removing hydrochloric acid (HC1) which is generated during this step, tertiary amines such as triethylamine, pyridine, N,N-dimethylaminopyridine, N-methylmorpholine, and bicyclic amines (e.g. DBN, DBU) can be used. It is preferable to use 1 to 5 equivalents of triethylamine or N-methylmorpholine. The reaction temperature is preferably selected between -40 °C and room temperature. Step 4
According to this step, (2R,3R)-epoxyamide compound of general formula (5) obtained from <Step 3> is reacted with an amine compound, a dehydrating agent and a Lewis acid. Firstly, in a reactor, the ketone group of (2R,3R)-epoxyamide compound (5) is substituted by an enamine, which then goes through intramolecular cyclization with Lewis acid to stereoselectively give trans-azetidinone.
As an amine compound, a dialkyl amine such as dimethylamine, diethylamine, dipropylamine or diisobutylamine; or a heterocyclic secondary amine such as pyrrolidine, piperidine, hexamethylene imine, morpholine, N-methyl piperazine, N-phenyl piperazine, azetidine or aziridine can be used. Pyrrolidine in an amount of 1 to 10 equivalents is preferably used. The dehydrating agents include phosphorus pentoxide, molecular sieve, magnesium sulfate, sodium sulfate and calcium chloride. As a chemical dehydrating agent, calcium hydride, titanium(IV) chloride or tris-dialkylaminoborane can be used.
The Lewis acids which can be used in this step include zinc chloride, zinc bromide, tin(IV) chloride, boranetrifluoride ethyl ether compound, aluminum chloride, lithium chloride, thallium chloride or titanium(IV) chloride and chlorotrimethylsilane. Titanium(IV) chloride is preferably used in an amount of 0.5 to 5 equivalents as a dehydrating agent and, at the same time, a Lewis acid. The reaction temperature is preferably selected between 0°C and reflux temperature.
As an organic solvent, benzene, dichloromethane, acetonitrile or tetrahydrofuran may be used. In particular, benzene or dichloromethane is preferably used. In case that zinc chloride or zinc bromide is used as a Lewis acid, the reaction may be performed in a milder condition as compared to the reaction using titanium(IV) chloride, but shows lower stereoselectivity.
If 0.1 to 10 equivalent of zinc chloride or zinc bromide is used, the reaction is preferably carried out by using 1 - 10 equivalents of pyrrolidine as an amine compound and 0.5 to 5 equivalents of phosphorus pentoxide as a dehydrating agent at a temperature between room temperature and reflux temperature in the presence of reaction solvent such as benzene, chloroform and acetonitrile.
As the present invention provides a process for stereoselective preparation of azetidinone ring starting from L-threonine which can be abundantly supplied from the nature, it is economically advantageous.
According to the invention, azetidinones can be prepared in a high yield and high stereoselectivity.
Best Mode for Carrying out the Invention The present invention is described in more detail with reference to the Examples. It should be noted that the scope of the present invention is not restricted to those Examples.
Example 1: (2R,3R)-Epoxybutyric acid After chilling 7.5N-HC1 (90 ml), L-threonine (17.86 g, 0.15 mol) was added thereto and dissolved therein. As maintaining the reaction temperature at room temperature, NaNθ2 (18.2 g) was added thereto in small portions over 5 hours. After cooling the interior temperature of the reactor to 0 °C , 40% solution of NaOH was slowly added dropwise, and the mixture stirred at room temperature for 15 hours. As restraining the elevation of the reaction temperature, the reaction mixture was acidified (to pH 2.0) with 6N-HC1, and then extracted from ethyl acetate (twice with each 400 ml). The combined organic layer was dried over anhydrous sodium sulfate (10 g), and concentrated under reduced pressure to obtain relatively pure title compound (14.3 g, yield: 93%). The product can be directly used in the next step without further purification.
Η-NMR(300MHz, CDCh, δ ) ; 1.44(d, J=5.33Hz, 3H), 3.38(m, 1H), 3.57(d, J=4.72Hz, 1H), 9 ~ 10(brs, lH)ppm.
Example 2; N-p-Methoxyphenyl-N-(acetyl)methylamine
To benzene (10 ml), p-anisidine (10 g, 0.08 mol), triethylamine (14.8 ml, 0.104 mol) and chloroacetone (8.4 ml, 0.14 mol) were added and the mixture was stirred under reflux condition for 30 minutes. After the reaction has been completed, the reaction mixture was cooled and extracted from dichloromethane (100 ml) and water (100 ml). The aqueous layer was extracted again with dichloromethane (50 ml). The combined organic layer was dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give crude solid product. The crude product was purified by a column chromatography (eluent: n- hexane/ethyl acetate = 2/1) to give pure yellow brown title compound (25.84 g, yield: 90%).
Η-NMR(300MHz, CDCh, δ ) ; 2.24(s, 3H), 3.74(s, 3H), 3.97(s, 2H), 4.28(brs, 1H), 6.57(d, J=6.7Hz, 2H), 6.79(d, J=6.7Hz, 2H)ppm.
Example 3; N-p-Methoxyphenyl-N-(benzoyl)methylamine
To benzene (2.5 ml), p-anisidine (5 g, 40.6 mmol), triethylamine (7.4 ml, 52.8 mmol) and chloroacetophenone (6.9 g, 44.5 mmol) were added and the mixture was stirred under reflux condition for 30 minutes. After the reaction has been completed, the reaction mixture was cooled and extracted from dichloromethane (100 ml) and water (100 ml). The aqueous layer was extracted again with dichloromethane (50 ml). The combined organic layer was dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give crude solid product. The crude product was purified by a column chromatography (eluent: n- hexane/ethyl acetate = 2/1) to give pure title compound as yellow solid (7.82 g, yield: 85%). Η-NMR(300MHz, CDCh, δ ) ; 3.76(s, 3H), 4.59(s, 3H),
6.7 l(d, J=9.4Hz, 2H), 6.78(d, J=9.4Hz, 2H), 7.49(m, 2H), 7.63(m, 1H), 8.02(m, 2H)ppm.
Example 4: (2R,3R)-N-(Acetyl)methyl-N-p-methoxyphenyI- 2,3- epoxy butyric amide
(2R,3R)-Epoxybutyric acid (14.3 g, 0.14 mol) was dissolved in chloroform (150 ml), and the solution chilled to -30 °C . N- methylmorpholine (20 ml, 0.18 mol) was added and ethylchloroformate (17.4 ml, 0.18 mol) was slowly added dropwise thereto. The mixture was stirred vigorously for 30 minutes. To the reaction mixture, N-p- methoxyphenyl-N-(acetyl)methyl-amine (22.58 g, 0.126 mol) prepared in
Example 2 was added, and the reaction temperature was raised to room temperature. Then the reaction mixture was stirred for 2 hours. After the completion of the reaction, the organic layer was washed with 2N-
HC1 and saturated solution of sodium bicarbonate, sequentially, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give crude title compound. The crude product was purified by a column chromatography (eluent: n-hexane/ethyl acetate = 1/2) to obtain pure title compound (28.16 g, yield: 86%) as brown oil.
'H-NMR(300MHz, CDCh, δ ) ; 1.42(d, J=5.37Hz, 3H), 2.16(s, 3H), 3.05(m, 1H), 3.30(d, J=4.5Hz, 1H), 3.83(s, 3H), 4.23(d, J=17.7Hz, 1H), 4.72(d, J=17.7Hz, 1H), 6.92(d, J=10Hz, 2H), 7.25(d, J=10Hz, 2H)ppm.
Example 5; (2R,3R)-N-(Benzoyl)methyl-N-p-methoxypheny 1-2,3- epoxy butyric amide
(2R,3R)-Epoxybutyric acid (1 1 g, 0.109 mol) was dissolved in chloroform (100 ml), and the solution chilled to -30°C . N- methylmorpholine (15.4 ml, 0.14 mol) was added and ethylchloroformate (13.4 ml, 0.14 mol) was slowly added dropwise thereto. The mixture was stirred vigorously for 30 minutes. To the reaction mixture, N-p- methoxyphenyl-N-(benzoyl)methyl-amine (22.2 g, 0.098 mol) prepared in Example 3 was added, and the reaction temperature was raised to room temperature. Then the reaction mixture was stirred for 2 hours. After the completion of the reaction, the organic layer was washed with 2N- HC1 and saturated solution of sodium bicarbonate, sequentially, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give crude title compound. The crude product was purified by a column chromatography (eluent: n-hexane/ethyl acetate = 1/2) to obtain pure title compound (25.78 g, yield: 85%) as yellow foam. Η-NMR(300MHz, CDCh, δ ) ; 1.47(d, J=5.35Hz, 3H), 3.09(m, 1H), 3.37(d, J=4.48Hz, 1H), 3.81(s, 3H), 4.86(d, J=17.3Hz, 1H), 5.42(d, J=17.3Hz, 1H), 6.92(d, J=9Hz, 2H), 7.34(d, J=9Hz, 2H), 7.45(m, 2H), 7.56(m, 1H), 7.92(m, 2H)ppm.
Example 6: (3S,4S)-3-[(lR)-Hydroxyethyl]-4-acetyl-l-p- methoxyphenyl-2-azetidinone (Method A) (2R,3R)-N-(Acetyl)methyl-N-p-methoxyphenyl-2,3-epoxy butyric amide (5 g, 19 mmol) prepared in Example 4 was dissolved in benzene (50 ml). The interior temperature of the reactor is lowered to 0 °C , and pyrrolidine (7.8 ml, 94.9 mmol) was added to the mixture. After stirring the reaction mixture for 5 minutes, titanium(IV) chloride (2.7 ml, 24.7 mmol) was slowly added dropwise. Upon the addition, a vigorous exothermic reaction occurred. After vigorously stirring the mixture for about 10 minutes, the reaction was quenched by adding 1N-HC1 (50 ml) at 10°C . The separated organic layer was washed with saturated solution of sodium bicarbonate and saturated brine sequentially, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give crude product (5.2 g). The crude product was purified by a column chromatography (eluent: n-hexane/ethyl acetate = 1/1) to obtain pure title compound (4.25 g, yield: 85%) as solid.
'H-NMR (300MHz, CDCb, δ ) ; 1.39(d, J= 6.37Hz, 3H), 2.25(s, 3H),
2.33(brs, 1H), 3.16(dd, J=2.64 and 5.26Hz, 1H), 3.78(s, 3H), 4.32(m, 1H), 4.56(d, J=2.64Hz, 1H), 6.87(d, J=6.87Hz, 2H),
7.2(d, J=6.8Hz, 2H)ppm.
(Method B)
N-(Acetyl)methyl-N-p-methoxyphenyl-2,3-epoxy butyric amide (4 g, 15.19 mmol) prepared in Example 4 was dissolved in chloroform (40 ml).
Sodium sulfate (2.16 g, 15.19 mmol), zinc chloride (3.73 g, 27.34 mmol) and pyrrolidine (2.66 ml, 31.9 mmol) were added thereto. The reaction temperature was then slowly raised to 60 °C , and the mixture was stirred for 3.5 hours. After cooling the reaction mixture to room temperature, the reaction was quenched by adding 2N-HC1 (40 ml). The separated organic layer was washed with saturated solution of sodium bicarbonate and saturated brine sequentially, and concentrated under reduced pressure to give crude product (5.2 g). The crude product was purified by a column chromatography (eluent: n-hexane/ethyl acetate = 1/1) to obtain pure title compound (4.0 g, yield: 80%) as solid, and bicyclic hemiketal compound (265 mg, 5.3 %).
Title compound :
Η-NMR(300MHz, CDCb, δ ) : identical to Example 6
Bicyclic hemiketal compound
Η-NMR(300MHz, CDCb, δ ) ; 1.41(s, 3H), 1.42(d, J=6.7Hz, 3H), 2.57(s, 1H), 3.65(d, J=4.3Hz, 1H), 3.79(s, 3H), 3.60(d, J=4.3Hz, 1H), 4.71(m, 1H), 6.88(d, J=10.1Hz, 2H), 7.33(d, J=10.1Hz, 2H)ppm. Example 7: (3S,4S)-3-[(lR)-Hydroxyethyl]-4-benzoyl-l-p- methoxyphenyl-2-azetidinone
The reaction was performed according to the same procedure described in Example 6, Method A, to give white solid product (4.35 g, yield: 86%). Η-NMR(300MHz, CDCh, δ ) ; 1.36(d, J=6.37Hz, 3H),
2.31(d, J=4.99Hz, 1H), 3.21(dd, J=2.37 and 6.33Hz, 1H), 3.70(s, 3H), 4.35(m, 1H), 5.53(d, J=2.37Hz, 1H), 4.80(d, J=6.8Hz, 2H), 7.18(d, J=6.8Hz, 2H), 7.55(m, 2H),
7.65(m, 1H), 8.18(m, 2H)ppm.
Comparative Example 1; (3S,4S)-3-[(lR)-Hydroxyethyl]-4- acetyl- l-p-methoxyphenyl-2-azetidinone (Method A)
(2R,3R)-N-(Acetyl)methyl-N-p-methoxyρhenyl-2,3-epoxy butyric amide (1 g, 3.8 mmol) prepared in Example 4 was dissolved in tetrahydrofuran (5 ml). The interior temperature of the reactor is lowered to 0°C . By adding lM-lithium hexamethyldisilazide (1M- LiHMDS) (4.94 ml, 4.94 mmol), the temperature was slowly raised to room temperature with stirring for 30 minutes. After the completion of the reaction, ethyl ether (10 ml) and saturated solution of ammonium chloride was added and the organic and aqueous layer was separated. The aqueous layer was extracted again with ethyl ether (10 ml). The combined organic layer was concentrated under reduced pressure, and the crude product was purified by column chromatography (eluent : n- hexane/ethyl acetate = 1/1) to obtain pure solid title compound (560 mg, yield: 56%) and bicyclic hemiketal compound 112 mg (yield: 11.2 %).
Title compound :
Η-NMR(300MHz, CDCb, δ ) : identical to Example 6 Bicyclic hemiketal compound :
'H-NMR(300MHz, CDCb, δ ) : identical to Example 6
(Method B) (2R,3R)-N-(Acetyl)methyl-N-p-methoxyphenyl-2,3-epoxy butyric amide (1 g, 3.8 mmol) prepared in Example 4 was dissolved in DMF (5 ml). Anhydrous potassium carbonate (683 mg, 4.94 mmol) was added thereto, and the mixture was reacted at 60 °C for 1 hour. After cooling the reaction mixture to room temperature, saturated ammonium chloride solution was added, and the resultant mixture was extracted from ethyl ether (10 ml). The separated aqueous layer was extracted again from ethyl ether (10 ml). The combined organic layer was concentrated under reduced pressure to give crude product. The crude product was purified by a column chromatography (eluent: n-hexane/ethyl acetate = 1/1) to obtain pure title compound (600 mg, yield: 60%) as solid, and bicyclic hemiketal compound (125 mg, 12.5 %).
Title compound :
Η-NMR(300MHz, CDCb, δ ) : identical to Example 6 Bicyclic hemiketal compound
'H-NMR(300MHz, CDCb, δ ) : identical to Example 6

Claims

1. A process for stereoselective preparation of azetidinone represented by general formula (1):
Figure imgf000016_0001
1
wherein, Ri represents a substituted or non-substituted aryl group, or a substituted or non-substituted lower alkyl group; and R2, as a protective group for ╬▓ -lactam ring, represents a substituted or non-substituted aryl group, or a substituted or non-substituted benzyl group, which comprises reacting the compound of general formula (5) with an amine compound, a dehydrating agent and a Lewis acid at a temperature between 0 ┬░C to the reflux temperature in the presence of benzene or dichloromethane solvent.
Figure imgf000016_0002
2. A process according to claim 1, wherein the amine compound is selected from the group consisting of dimethylamine, diethylamine, dipropylamine, diisobutylamine, pyrrolidine, piperidine, hexamethylene imine, morpholine, N-methyl piperazine, N-phenyl piperazine, azetidine and aziridine.
3. A process according to claim 1, wherein the amine compound is pyrrolidine in an amount of 1 to 10 equivalents.
4. A process according to claim 1, wherein the dehydrating agent is phosphorus pentoxide, molecular sieve, magnesium sulfate, sodium sulfate, calcium chloride, calcium hydride, titanium(IV) chloride or tris- dialkylaminoborane.
5. A process according to claim 1, wherein the dehydrating agent is titanium(IV) chloride or phosphorus pentoxide in an amount of 0.5 to 5 equivalent, respectively.
6. A process according to claim 1, wherein the Lewis acid is borane trifluoride ethyl ether, zinc chloride, zinc bromide, tin(IV) chloride, aluminum chloride, lithium chloride, thallium chloride or titanium(IV) chloride.
7. A process according to claim 1, wherein the Lewis acid is zinc chloride or zinc bromide in an amount of 0.1 to 10 equivalents.
8. A process according to claim 1, wherein 0.5 to 5 equivalents of titanium(IV) chloride is used as the dehydrating agent and, at the same time, the Lewis acid.
PCT/KR1997/000070 1997-04-10 1997-04-30 Process for stereoselective preparation of azetidinones WO1998045260A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU27130/97A AU2713097A (en) 1997-04-10 1997-04-30 Process for stereoselective preparation of azetidinones

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1997/13266 1997-04-10
KR1019970013266A KR100205767B1 (en) 1997-04-10 1997-04-10 Stereoselective preparation method of azetidinone

Publications (1)

Publication Number Publication Date
WO1998045260A1 true WO1998045260A1 (en) 1998-10-15

Family

ID=19502454

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR1997/000070 WO1998045260A1 (en) 1997-04-10 1997-04-30 Process for stereoselective preparation of azetidinones

Country Status (3)

Country Link
KR (1) KR100205767B1 (en)
AU (1) AU2713097A (en)
WO (1) WO1998045260A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007029650A1 (en) * 2005-09-05 2007-03-15 Meiji Seika Kaisha, Ltd. SYNTHESIS INTERMEDIATE FOR 1β-METHYLCARBAPENEM DERIVATIVE AND METHOD FOR PRODUCING SAME
CN102108058A (en) * 2010-12-13 2011-06-29 吉林医药学院 Cyclization reaction method of epoxy butyramide used in the synthesis of 4-AA (3R,4R)-4-acetoxy-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-2-azetidinone
CN102432632A (en) * 2011-09-16 2012-05-02 上海悦昂化学有限公司 Method for preparing (3R,4R)-3-[(1R)tert-butyl-dimethyl-silyloxyethyl]-4-acetoxyl-2-azetidinone
CN102491912A (en) * 2011-12-28 2012-06-13 上海新先锋药业有限公司 Synthesizing method of N-methoxyphenyl-N-(acetyl)methylamine
CN104130173A (en) * 2014-06-30 2014-11-05 江苏瑞克医药科技有限公司 Method for improving N-(4-methoxyphenyl)-4-acetyl-3-(1-hydroxyl)ethylazetidinone-2 synthesis conversion rate
CN105001182A (en) * 2015-06-26 2015-10-28 上海应用技术学院 Preparation method of (2R, 3R)-N-(benzoyl)methyl-N-4-methoxyphenyl-2, 3-epoxy butyramide
CN112390722A (en) * 2019-08-13 2021-02-23 浙江瑞博制药有限公司 Continuous flow process for amine alkylation reaction

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181831A2 (en) * 1984-10-01 1986-05-21 Ciba-Geigy Ag Process for the preparation of optically active acyloxyazetidinones
EP0240164A2 (en) * 1986-03-03 1987-10-07 Schering Corporation Preparation of azetidinones
EP0276993A1 (en) * 1987-01-30 1988-08-03 Zeneca Limited Process for preparing azetidinones
JPH03279356A (en) * 1990-03-29 1991-12-10 Nippon Shokubai Co Ltd Production of 2-azetidinone derivative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181831A2 (en) * 1984-10-01 1986-05-21 Ciba-Geigy Ag Process for the preparation of optically active acyloxyazetidinones
EP0240164A2 (en) * 1986-03-03 1987-10-07 Schering Corporation Preparation of azetidinones
EP0276993A1 (en) * 1987-01-30 1988-08-03 Zeneca Limited Process for preparing azetidinones
JPH03279356A (en) * 1990-03-29 1991-12-10 Nippon Shokubai Co Ltd Production of 2-azetidinone derivative

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Vol. 102, No. 13, 01 April 1985, (Columbus, Ohio, USA) page 676, Abstract No. 113121h, HANESSIAN ST., "A New Synthetic Strategy for the Penems. Total Synthesis of (5R,6S,8R)-6-(alpha-Hydroxymethyl)-2-(Hydro xymethyl)Penem-3-Carboxylic Acid"; & J. AM. CHEM. SOC., 1985, 107(5), 1438-9 (Eng). *
CHEMICAL ABSTRACTS, Vol. 114, No. 3, 21 January 1991, (Columbus, Ohio, USA) page 669, Abstract No. 23601h, KUGELMANN M. et al., "Synthesis of Azetidinones from L-Threonine: Formation of Unusually Stable Bicyclic Hemiketals and Cis-Azetidinones"; & SYNLETT., 1990, (7), 431-2 (Eng). *
CHEMICAL ABSTRACTS, Vol. 116, No. 25, 22 June 1992, (Columbus, Ohio, USA) page 766, Abstract No. 255396q, UENO TSUNEMASA et al., "Preparation of 2-Azetidinone Derivatives"; & JP,A,03 279 356 (10-12-91). *
CHEMICAL ABSTRACTS, Vol. 122, No. 13, 27 March 1995, (Columbus, Ohio, USA) page 929, Abstract No. 159898h, GROSJEAN F., "Molecular Modeling Study of the Regioselectivity of the Opening of Glycidic Acids by Aliphatic Amines"; & TETRAHEDRON, 1994, 50(31), 9325-34 (Fr). *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007029650A1 (en) * 2005-09-05 2007-03-15 Meiji Seika Kaisha, Ltd. SYNTHESIS INTERMEDIATE FOR 1β-METHYLCARBAPENEM DERIVATIVE AND METHOD FOR PRODUCING SAME
JP5112070B2 (en) * 2005-09-05 2013-01-09 Meiji Seikaファルマ株式会社 Intermediate for synthesizing 1β-methylcarbapenem derivative and process for producing the same
CN102108058A (en) * 2010-12-13 2011-06-29 吉林医药学院 Cyclization reaction method of epoxy butyramide used in the synthesis of 4-AA (3R,4R)-4-acetoxy-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-2-azetidinone
CN102108058B (en) * 2010-12-13 2012-12-26 吉林医药学院 Cyclization reaction method of epoxy butyramide used in the synthesis of 4-AA
CN102432632A (en) * 2011-09-16 2012-05-02 上海悦昂化学有限公司 Method for preparing (3R,4R)-3-[(1R)tert-butyl-dimethyl-silyloxyethyl]-4-acetoxyl-2-azetidinone
CN102491912A (en) * 2011-12-28 2012-06-13 上海新先锋药业有限公司 Synthesizing method of N-methoxyphenyl-N-(acetyl)methylamine
CN104130173A (en) * 2014-06-30 2014-11-05 江苏瑞克医药科技有限公司 Method for improving N-(4-methoxyphenyl)-4-acetyl-3-(1-hydroxyl)ethylazetidinone-2 synthesis conversion rate
CN105001182A (en) * 2015-06-26 2015-10-28 上海应用技术学院 Preparation method of (2R, 3R)-N-(benzoyl)methyl-N-4-methoxyphenyl-2, 3-epoxy butyramide
CN112390722A (en) * 2019-08-13 2021-02-23 浙江瑞博制药有限公司 Continuous flow process for amine alkylation reaction

Also Published As

Publication number Publication date
KR19980076532A (en) 1998-11-16
KR100205767B1 (en) 1999-07-01
AU2713097A (en) 1998-10-30

Similar Documents

Publication Publication Date Title
PL177891B1 (en) Method of obtaining florphenicol, thiamphenicol and chloramphenicol as well as intermediate compounds of oxazoline type by dissymmetrical synthesis
KR100205769B1 (en) Stereoselective preparation method of transazetidinone
KR101156588B1 (en) Method of preparing ezetimibe and intermediates used therein
KR950013767B1 (en) Chiral azetidinone derivatives and method for preparing them
TWI438188B (en) Production method of intermediate compound for synthesizing medicament
WO1998045260A1 (en) Process for stereoselective preparation of azetidinones
MX2007000907A (en) Synthesis of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides.
RU2362766C2 (en) Method of obtaining benzylamine derivative and acylbenzylamine derivative
US7064199B2 (en) Process for the manufacture of 3-amino-pyrrolidine derivatives
US7276611B2 (en) Process for synthesizing beta-lactamase inhibitor intermediates
JP4181233B2 (en) Method for producing pyrrolidine-2,4-dione derivative
JP3523921B2 (en) Azaspiro derivative and method for producing the same
US6531594B2 (en) Process for producing 1H-3-aminopyrrolidine and derivatives thereof
US6388083B2 (en) Process for the synthesis of (2S)-phenyl-3-piperidone
JP3388874B2 (en) Method for producing β-lactam compound
KR0182192B1 (en) Selective process for preparing optically active (3r,4s)-3-alkoxy-4-phenyl-2-azetidinone
JPWO2004099136A1 (en) Method for producing pyrrolidine derivative
EP0947505B1 (en) Process for preparing optically active 4-hydroxy-2-pyrrolidone
JP3159518B2 (en) Preparation of amino-substituted spiro compounds
JP2004300036A (en) beta-ALANINE DERIVATIVE AND METHOD FOR PRODUCING THE SAME
JP3013760B2 (en) Method for producing 4-hydroxy-2-pyrrolidone
JPH05221947A (en) Production of cyclopropane derivative
KR20040099963A (en) Chiral 2-azetidinone compounds, process and use thereof
WO2000053575A1 (en) SYNTHESIS OF α-AMINO-α&#39;,α&#39;-DIHALOKETONES AND PROCESS FOR THE PREPARATION OF β-AMINO ACID DERIVATIVES BY THE USE OF THE SAME
JPH05500210A (en) How to make penem

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998542614

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA